Portal de investigación
Targeting the senescent surfaceome through DPP4 antibody-functionalized nanoparticles. An application to cancer therapy.
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Montoya-Méndez I
Grupos
Abstract
Due to the heterogeneity of the senescent phenotype and the lack of a universal biomarker of senescence, the targeting of senescent cells is still an unresolved challenge, and the elimination of senescent cells using specific drugs (senolytics) is still limited in clinical use due to the off-target effects and associated toxicities of current therapeutic strategies. In this study, the induction of senescence in human melanoma cells by palbociclib is found to lead to a senescent phenotype characterized by overexpression of the membrane protein dipeptidyl peptidase 4 (DPP4), previously identified only in ageing contexts. Based on this discovery, a nanoparticle targeting DPP4 overexpression in the senescent surfaceome is designed, synthesized, and characterized to target senescent cancer cells. The nanoparticle based on mesoporous silica is loaded with the senolytic navitoclax, coated with disulfide-containing poly(ethylene glycol) to generate a redox-sensitive gatekeeper (S-S-PEG), and functionalized with an antibody against the DPP4 protein. The ability of the nanoparticles to effectively detect and eliminate senescent cells was confirmed in vitro and in vivo using a mouse model of palbociclib-induced senescent in melanoma. The DPP4-targeted nanoparticle effectively reduces tumor growth and selectively removes senescent cells. Taken together, this study highlights the potential of surfaceome-targeted nanoparticles, as a clinically relevant strategy for improving senolytic therapies.
Copyright © 2025 The Authors. Published by Elsevier Ltd.. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 0142-9612, 1878-5905
- Tipo:
- Article
- Páginas:
- 123461-123461
- PubMed:
- 40494025
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 2,678 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
BIOMATERIALS ELSEVIER SCI LTD
Citas Recibidas en Web of Science: 5
Documentos
- No hay documentos
Filiaciones
Keywords
- Dipeptidyl peptidase 4; Mesoporous silica nanoparticle; Navitoclax; Senescence
Cita
ESCRICHE B,GARRIDO E,ESCUDERO A,Montoya I,SANCENÓN F,GARCÍA A,MARTÍNEZ R. Targeting the senescent surfaceome through DPP4 antibody-functionalized nanoparticles. An application to cancer therapy. Biomaterials. 2025. 324. p. 123461-123461. IF:13,600. (1).